⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 1, 2024Open Access

Supplementary Figure S14 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

Brian Mooney Gian Luca Negri Taras Shyp Alberto Delaidelli Hai‐Feng Zhang Sandra E. Spencer Miko Amber K. Weiner Alexander B. Radaoui Rawan Shraim Michael M. Lizardo Christopher S. Hughes Amy Li Amal M. El-Naggar Mélanie Rouleau Wei Li Dimiter S. Dimitrov Raushan T. Kurmasheva Peter J. Houghton Sharon J. Diskin John M. Maris Gregg B. Morin Poul H. Sorensen

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

ENPP1 is expressed at higher levels in non-metastatic EwS vs metastatic EwS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mooney et al. (2024) studied this question.

synapsesocial.com/papers/68e7681cb6db6435876dd04e https://doi.org/10.1158/1078-0432.25324178

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S14 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma2024
2Supplementary Figure S5 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma2024
3Supplementary Figure S5 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma2024
4Supplementary Figure S11 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma2024
5Supplementary Figure S11 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma2024